HRT Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Buy |
79,824
+45,389
| +132% | +$1.65M | 0.01% | 617 |
|
|
2025
Q1 | $1.25M | Buy |
34,435
+5,935
| +21% | +$215K | 0.01% | 883 |
|
|
2024
Q4 | $1.2M | Buy |
28,500
+4,825
| +20% | +$203K | 0.01% | 849 |
|
|
2024
Q3 | $1.32M | Buy |
+23,675
| New | +$1.32M | 0.01% | 1011 |
|
|
2024
Q2 | – | Sell |
-7,869
| Closed | -$367K | – | 2760 |
|
|
2024
Q1 | $367K | Sell |
7,869
-10,430
| -57% | -$486K | ﹤0.01% | 1354 |
|
|
2023
Q4 | $875K | Buy |
+18,299
| New | +$875K | 0.01% | 980 |
|
|
2023
Q3 | – | Sell |
-59,300
| Closed | -$2.74M | – | 2704 |
|
|
2023
Q2 | $2.74M | Buy |
59,300
+48,838
| +467% | +$2.25M | 0.03% | 454 |
|
|
2023
Q1 | $419K | Sell |
10,462
-20,022
| -66% | -$802K | 0.01% | 1395 |
|
|
2022
Q4 | $1.41M | Buy |
+30,484
| New | +$1.41M | 0.02% | 705 |
|
|
2021
Q3 | – | Sell |
-156,948
| Closed | -$15M | – | 3419 |
|
|
2021
Q2 | $15M | Buy |
+156,948
| New | +$15M | 0.14% | 129 |
|